MediciNova, Inc.

/MediciNova, Inc.

Secondary

MediciNova, Inc.

They are a publicly-traded biopharmaceutical company founded upon acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market.

Symbol

MNOV

Last Closing Price
$9.73

Shares
4,300,000

Effective Date
February 8, 2018

Underwriters
Ladenburg Thalmann

To view the prospectus for MediciNova, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277